Consolidated Statement Of Income

BrightPath Biotherapeutics Co., Ltd. - Filing #7580404

Concept 2019-04-01 to
2020-03-31
2019-04-01 to
2020-03-31
2019-04-01 to
2020-03-31
2019-04-01 to
2020-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
Consolidated statement of income
Statement of income
Net sales
11,300,000 JPY
155,808,000 JPY
Cost of sales
4,467,000 JPY
70,702,000 JPY
Operating expenses
Operating expenses - general
Remuneration for directors (and other officers)
58,300,000 JPY
62,425,000 JPY
Depreciation
177,000 JPY
868,000 JPY
Operating expenses
Selling, general and administrative expenses
1,834,182,000 JPY
1,750,655,000 JPY
Operating expenses
Operating profit (loss)
-1,827,349,000 JPY
-1,665,548,000 JPY
Gross profit (loss)
6,832,000 JPY
85,106,000 JPY
Net sales
Ordinary profit (loss)
-1,823,996,000 JPY
-1,678,084,000 JPY
Operating expenses
Research and development expenses
1,484,854,000 JPY
1,387,674,000 JPY
General and administrative expenses
Salaries
Selling, general and administrative expenses
Non-operating income
Interest income
42,000 JPY
1,762,000 JPY
Other
357,000 JPY
665,000 JPY
Non-operating income
3,409,000 JPY
20,111,000 JPY
Cost of sales
Extraordinary income
12,550,000 JPY
JPY
Non-operating expenses
Non-operating expenses
56,000 JPY
32,647,000 JPY
Extraordinary losses
48,415,000 JPY
202,445,000 JPY
Impairment losses
48,159,000 JPY
194,829,000 JPY
Other
JPY
415,000 JPY
Profit (loss) before income taxes
-1,859,861,000 JPY
-1,880,529,000 JPY
Gross profit
Extraordinary income
Gain on sale of non-current assets
95,000 JPY
JPY
Income taxes - current
2,732,000 JPY
3,670,000 JPY
Extraordinary losses
Loss on sale of non-current assets
255,000 JPY
JPY
Income taxes - deferred
-4,819,000 JPY
118,000 JPY
Income taxes
-2,087,000 JPY
3,788,000 JPY
Profit (loss)
-1,857,774,000 JPY
-1,857,774,000 JPY
-1,857,774,000 JPY
-1,857,774,000 JPY
-1,884,318,000 JPY
-1,884,318,000 JPY
-1,884,318,000 JPY
-1,884,318,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.